{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:00:40Z","timestamp":1793016040672,"version":"4.5.0"},"reference-count":25,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.3960\/jslrt.19040","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T22:06:17Z","timestamp":1596837977000},"page":"97-102","source":"Crossref","is-referenced-by-count":2,"title":["Significant role of magnetic resonance imaging for the diagnosis and evaluation of cardiac amyloidosis in primary light chain amyloidosis"],"prefix":"10.3960","volume":"60","author":[{"given":"Yasunobu","family":"Sekiguchi","sequence":"first","affiliation":[{"name":"Department of Hematology, Juntendo University Urayasu Hospital, Urayasu-shi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsumi","family":"Wakabayashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Urayasu Hospital, Urayasu-shi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Iizuka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Urayasu Hospital, Urayasu-shi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Takizawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Urayasu Hospital, Urayasu-shi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Urayasu Hospital, Urayasu-shi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakura","family":"Sakajiri","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Urayasu Hospital, Urayasu-shi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadaaki","family":"Inano","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Hospital, Bunkyo-ku, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Fukuda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Hospital, Bunkyo-ku, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuharu","family":"Hamano","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Hospital, Bunkyo-ku, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Tomita","sequence":"additional","affiliation":[{"name":"Department of Pathology, Juntendo University Urayasu Hospital, Urayasu-shi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Juntendo University Urayasu Hospital, Urayasu-shi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Isogai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Juntendo University Urayasu Hospital, Urayasu-shi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Okubo","sequence":"additional","affiliation":[{"name":"Department of Transfusion Medicine, Juntendo University Urayasu Hospital, Urayasu-shi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Juntendo University Urayasu Hospital, Urayasu-shi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Juntendo University Urayasu Hospital, Urayasu-shi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihiro","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Tokyo Dental University Ichikawa General Hospital, Ichikawa-shi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Juntendo University Urayasu Hospital, Urayasu-shi, Japan,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003; 349: 583-596.","DOI":"10.1056\/NEJMra023144"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Dispenzieri A, Gertz MA, Kyle RA <i>et al.<\/i> Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol. 2004; 22: 3751-3757.","DOI":"10.1200\/JCO.2004.03.029"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Kumar S, Dispenzieri A, Lacy MQ <i>et al.<\/i> Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol. 2012; 30: 989-995.","DOI":"10.1200\/JCO.2011.38.5724"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997; 337: 898-909.","DOI":"10.1056\/NEJM199709253371306"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Wechalekar AD, Gillmore JD, Bird J <i>et al.<\/i> BCSH Committee. Guidelines on the management of AL amyloidosis. Br J Haematol. 2015; 168: 186-206.","DOI":"10.1111\/bjh.13155"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 D\u2019Souza A, Dispenzieri A, Wirk B <i>et al.<\/i> Improved outcomes after autologous hematopoietic cell transplantation for light chain amyloidosis: A Center for International Blood and Marrow Transplant Research Study. J Clin Oncol. 2015; 33: 3741-3749.","DOI":"10.1200\/JCO.2015.62.4015"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Tsai SB, Seldin DC, Quillen K <i>et al.<\/i> High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center. Blood. 2012; 120: 4445-4446.","DOI":"10.1182\/blood-2012-09-457341"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Jimenez-Zepeda VH, Franke N, Reece DE <i>et al.<\/i> Autologous stem cell transplant is an effective therapy for carefully selected patients with AL amyloidosis: experience of a single institution. Br J Haematol. 2014; 164: 722-728.","DOI":"10.1111\/bjh.12673"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Sher T, Dispenzieri A, Gertz MA. Evolution of hematopoietic cell transplantation for immunoglobulin light chain amyloidosis. Biol Blood Marrow Transplant. 2016; 22: 796-801.","DOI":"10.1016\/j.bbmt.2015.10.010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Gertz MA, Lacy MQ, Dispenzieri A <i>et al.<\/i> Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis. Bone Marrow Transplant. 2013; 48: 557-561.","DOI":"10.1038\/bmt.2012.170"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Girnius S, Seldin DC, Meier-Ewert HK <i>et al.<\/i> Safety and efficacy of high-dose melphalan and auto-SCT in patients with AL amyloidosis and cardiac involvement. Bone Marrow Transplant. 2014; 49: 434-439.","DOI":"10.1038\/bmt.2013.192"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Gertz MA, Comenzo R, Falk RH <i>et al.<\/i> Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol. 2005; 79: 319-328.","DOI":"10.1002\/ajh.20381"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Gillmore JD, Wechalekar A, Bird J <i>et al.<\/i> BCSH Committee. Guidelines on the diagnosis and investigation of AL amyloidosis. Br J Haematol. 2015; 168: 207-218.","DOI":"10.1111\/bjh.13156"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Dispenzieri A, Lacy MQ, Kyle RA <i>et al.<\/i> Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival. J Clin Oncol. 2001; 19: 3350-3356.","DOI":"10.1200\/JCO.2001.19.14.3350"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Skinner M, Sanchorawala V, Seldin DC <i>et al.<\/i> High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med. 2004; 140: 85-93.","DOI":"10.7326\/0003-4819-140-2-200401200-00008"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Wechalekar AD, Hawkins PN, Gillmore JD. Perspectives in treatment of AL amyloidosis. Br J Haematol. 2008; 140: 365-377.","DOI":"10.1111\/j.1365-2141.2007.06936.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Tsukada N, Ikeda M, Shingaki S <i>et al.<\/i> High-dose melphalan and autologous stem cell transplantation for systemic light-chain amyloidosis: a single institution retrospective analysis of 40 cases. Int J Hematol. 2016; 103: 299-305.","DOI":"10.1007\/s12185-015-1922-x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Hayashi T, Ikeda H, Igarashi T <i>et al.<\/i> Autologous stem cell transplantation for AL amyloidosis: adjustment of melphalan dose by factors including BNP. Int J Hematol. 2014; 100: 554-558.","DOI":"10.1007\/s12185-014-1680-1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Gertz MA, Lacy MQ, Dispenzieri A <i>et al.<\/i> Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006. Bone Marrow Transplant. 2011; 46: 970-975.","DOI":"10.1038\/bmt.2010.234"},{"key":"20","unstructured":"20 Perfetti V, Siena S, Palladini G <i>et al.<\/i> Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis. Haematologica. 2006; 91: 1635-1643."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Comenzo RL, Gertz MA. Autologous stem cell transplantation for primary systemic amyloidosis. Blood. 2002; 99: 4276-4282.","DOI":"10.1182\/blood.V99.12.4276"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Comenzo RL, Reece D, Palladini G <i>et al.<\/i> Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis. Leukemia. 2012; 26: 2317-2325.","DOI":"10.1038\/leu.2012.100"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Lin L, Li X, Feng J <i>et al.<\/i> The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis. J Cardiovasc Magn Reson. 2018; 20: 2.","DOI":"10.1186\/s12968-017-0419-6"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Donnelly JP, Hanna M. Cardiac amyloidosis: an update on diagnosis and treatment. Cleve Clin J Med. 2017; 84(suppl 3): 12-26.","DOI":"10.3949\/ccjm.84.s3.02"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Oda S, Utsunomiya D, Nakaura T <i>et al.<\/i> Role of noninvasive diagnostic imaging in cardiac amyloidosis: A review. Cardiovascular Imaging Asia. 2018; 2: 97-106.","DOI":"10.22468\/cvia.2018.00059"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/60\/3\/60_19040\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T00:54:48Z","timestamp":1616892888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/60\/3\/60_19040\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.19040","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}